...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >In vitro elution of vancomycin from biodegradable beads.
【24h】

In vitro elution of vancomycin from biodegradable beads.

机译:从可生物降解的珠子中洗脱万古霉素。

获取原文
获取原文并翻译 | 示例
           

摘要

The current antibiotics delivery system for orthopedic infection treatment uses polymethylmethacrylate (PMMA) beads as a drug release. However the nonbiodegradable nature of the PMMA necessitates a second operation to remove the beads. This article explores the alternative of using biodegradable polymers as antibiotic beads for a long-term drug release. The effect of different processing factors on the release rate of the beads was investigated. To manufacture an antibiotic bead, polylactide-polyglycolide copolymers were mixed with vancomycin. The mixture was compressed and sintered at 55 degrees C to form beads of different sizes. An elution method was employed to characterize the release rate of antibiotic over a 35-day period at 37 degrees C. Biodegradable beads released high concentrations of antibiotic (well above the breakpoint sensitivity concentration) in vitro for the period of time needed to treat bone infection; i.e., 4-6 weeks. A bacterial inhibition test was carried out to determine the relative activity of the released antibiotics. The diameter of the sample inhibition zone ranged from 6.5-10 mm, which is equivalent to 12.5-100% of relative activity. By changing the processing parameters, we were able to control the release rate of the beads. This provides advantages of meeting the specific antibiotics requirement for patients with various surgical infections. Copyright 1999 John Wiley & Sons, Inc.
机译:当前用于骨科感染治疗的抗生素输送系统使用聚甲基丙烯酸甲酯(PMMA)珠作为药物释放。然而,PMMA的不可生物降解的性质需要第二操作以去除珠子。本文探讨了使用可生物降解的聚合物作为抗生素珠粒以长期释放药物的替代方法。研究了不同加工因素对珠粒释放速率的影响。为了制造抗生素珠,将聚丙交酯-聚乙交酯共聚物与万古霉素混合。将混合物压缩并在55℃下烧结以形成不同尺寸的珠。采用洗脱方法来表征37摄氏度下35天期间抗生素的释放速率。可生物降解的珠粒在体外治疗骨骼感染所需的时间内释放出高浓度的抗生素(远高于断点敏感性浓度) ;即4-6周。进行了细菌抑制试验以确定释放的抗生素的相对活性。样品抑制区的直径范围为6.5-10 mm,相当于相对活性的12.5-100%。通过更改加工参数,我们能够控制珠粒的释放速率。这提供了满足各种外科感染患者特定抗生素需求的优势。版权所有1999 John Wiley&Sons,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号